EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON BLOOD RHEOLOGY OF RAT

被引:0
|
作者
MAEDA, N [1 ]
SHIGA, T [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT PHYSIOL,SUITA,OSAKA 565,JAPAN
来源
CLINICAL HEMORHEOLOGY | 1994年 / 14卷 / 01期
关键词
ERYTHROPOIETIN (RECOMBINANT HUMAN); RED CELL DEFORMABILITY; RED CELL AGGREGATION; VISCOSITY; ORGANIC PHOSPHATES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human erythropoietin (rhEPO; 180 or 1800 IU per kg) was daily administered to 6 weeks old rats for 1 to 2 weeks. [1] The increase of blood viscosity in rhEPO-administered rats in a saturation manner entirely depends on the hematocrit (the plasma viscosity and the plasma protein composition were not altered by rhEPO-administration). [2] No change in red cell deformability was observed upon rhEPO administration. [3] The velocity of rouleaux formation in autologous plasma decreased in rhEPO-administered rats. [4] A considerable polycythemia with reticulocytosis was induced in dose- and duration-dependent manners but in a saturation manner: cell volume increased and intracellular hemoglobin concentration inversely decreased. The density distribution of red cells shifted towards low specific gravity and became heterogenous. [5] No drastic alterations in contents of 2,3-diphosphoglycerate and ATP were detected. In conclusion, the increase of blood viscosity upon daily administration of rhEPO was hematocrit-dependent, regardless of the appearance of red cells with large volume and low internal viscosity.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 50 条
  • [31] THE SAFETY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN AUTOLOGOUS BLOOD-DONORS
    GOODNOUGH, LT
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 124 (01): : 17 - 18
  • [32] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HOSPITALIZATION OF HEMODIALYSIS-PATIENTS
    CHURCHILL, DN
    MUIRHEAD, N
    GOLDSTEIN, M
    POSEN, G
    FAY, WF
    BEECROFT, ML
    GORMAN, J
    TYLOR, DW
    CLINICAL NEPHROLOGY, 1995, 43 (03) : 184 - 188
  • [33] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLATELET PRODUCTION IN DIALYSIS PATIENTS
    KAUPKE, CJ
    BUTLER, GC
    VAZIRI, ND
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (10): : 1672 - 1679
  • [34] AUTOLOGOUS BLOOD-TRANSFUSION WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEART OPERATIONS
    WATANABE, Y
    FUSE, K
    KONISHI, T
    KOBAYASI, T
    TAKAZAWA, K
    KONISHI, H
    SHIBATA, Y
    ANNALS OF THORACIC SURGERY, 1991, 51 (05): : 767 - 772
  • [35] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON CEREBRAL AND CUTANEOUS BLOOD-FLOW AND ON BLOOD COAGULABILITY
    JOHNSON, WJ
    MCCARTHY, JT
    YANAGIHARA, T
    OSMUNDSON, PJ
    ILSTRUP, DM
    JENSON, BM
    BOWIE, EJW
    KIDNEY INTERNATIONAL, 1990, 38 (05) : 919 - 924
  • [36] RECOMBINANT-HUMAN-ERYTHROPOIETIN TO CORRECT UREMIC BLEEDING
    VIGANO, G
    BENIGNI, A
    MENDOGNI, D
    MINGARDI, G
    MECCA, G
    REMUZZI, G
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) : 44 - 49
  • [37] TREATING RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    ROSS, CN
    REES, AJ
    BRITISH MEDICAL JOURNAL, 1990, 300 (6731): : 1078 - 1079
  • [38] EARLY INTERVENTION WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
    TEEHAN, BP
    BENZ, RL
    SIGLER, MH
    BROWN, JM
    SEMINARS IN NEPHROLOGY, 1990, 10 (02) : 28 - 34
  • [39] RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES
    RAFANELLI, D
    GROSSI, A
    LONGO, G
    VANNUCCHI, AM
    BACCI, P
    FERRINI, PR
    LEUKEMIA, 1992, 6 (04) : 323 - 327
  • [40] PREPARATION OF IODINE LABELED RECOMBINANT-HUMAN-ERYTHROPOIETIN
    KINOSHITA, H
    OHISHI, N
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1991, 41-1 (05): : 568 - 570